Quest Diagnostics
DGX
#1122
Rank
โ‚น1.916 T
Marketcap
โ‚น17,140
Share price
2.57%
Change (1 day)
21.63%
Change (1 year)
Quest Diagnostics is an American clinical laboratory company offering access to diagnostic testing services for cancer, cardiovascular disease, infectious disease, neurological disorders and employment and court ordered drug testing.

EPS for Quest Diagnostics (DGX)

EPS in 2025 (TTM): โ‚น747.04

According to Quest Diagnostics 's latest financial reports the company's current EPS (TTM) is โ‚น791.78. In 2024 the company made an earnings per share (EPS) of โ‚น712.97 an increase over its 2023 EPS that were of โ‚น695.56.

EPS history for Quest Diagnostics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น747.044.78%
2024โ‚น712.972.5%
2023โ‚น695.56-5.83%
2022โ‚น738.63-49.21%
2021โ‚น1,45449.72%
2020โ‚น971.3966.67%
2019โ‚น582.8418%
2018โ‚น493.94-4.26%
2017โ‚น515.9423.19%
2016โ‚น418.80-7.11%
2015โ‚น450.8728.46%
2014โ‚น350.99-31.61%
2013โ‚น513.1960.46%
2012โ‚น319.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
LabCorp
LH
โ‚น939.32 18.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Psychemedics
PMD
-โ‚น65.23-108.24%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น80.64-110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
โ‚น171.25-78.37%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Enzo Biochem
ENZB
-โ‚น19.24-102.43%๐Ÿ‡บ๐Ÿ‡ธ USA